HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation].

Abstract
A 3-year-old girl with acute myeloid leukemia underwent unrelated cord blood stem cell transplantation (UCBT) due to primary induction failure. Fourteen days after UCBT, she developed central venous catheter (CVC)-related bloodstream infection due to Chryseobacterium indologenes. Despite ciprofloxacin and minocycline being administered according to the results of susceptibility, a high grade fever recurred. Therefore, the CVC was removed 21 days after UCBT and symptoms related to CVC infection improved. Although C. indologenes is widely distributed in nature, it is a rare pathogen in humans. Most cases of C. indologenes bacteremia have been found in immunocompromised patients with malignancies and diabetes mellitus. C. indologenes exhibits specific characteristics, including the progression of resistance to antibiotics and the formation of a biofilm. Therefore, removal of the CVC appears to be the most reasonable treatment for CVC infection due to C. indologenes in patients undergoing hematopoietic stem cell transplantation if clinical symptoms do not improve after appropriate antibiotic therapy.
AuthorsYuichi Kodama, Miho Nishimura, Kentaro Nakashima, Nobuhiro Ito, Reiji Fukano, Jun Okamura, Jiro Inagaki
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 54 Issue 3 Pg. 305-10 (Mar 2013) ISSN: 0485-1439 [Print] Japan
PMID23676648 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Bacteremia (microbiology)
  • Catheter-Related Infections (microbiology)
  • Catheterization, Central Venous (adverse effects)
  • Chryseobacterium (isolation & purification)
  • Female
  • Flavobacteriaceae Infections (microbiology, therapy)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: